UnitedHealth Group Inc (UNH) operating KPIs
UNHNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026Score 11/30
$406.97−3.94 (-0.96%)
Close on Oct 30, 2026Market cap $365.29BP/E 26.2Yield 2.15%
KPIs
Operating metrics that drive UnitedHealth's business · fiscal year ends December 31
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q3 2026 2026-09-30 | Q2 2026 2026-06-30 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 | Q1 2025 2025-03-31 | Q4 2024 2024-12-31 | Q3 2024 2024-09-30 | Q2 2024 2024-06-30 | Q1 2024 2024-03-31 | Q4 2023 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
UnitedHealthcare — Total Medical Benefits People Served (Domestic)4 | 48,300.00 | 48,525.00 | 49,050.00 | 49,760.00 | 50,125.00 | 50,115.00 | 50,125.00 | 49,345.00 | 49,330.00 | 49,085.00 | 49,180.00 | 47,210.00 | |
Commercial — Total People Served (Domestic)2 | 29,755.00 | 29,920.00 | 30,065.00 | 29,650.00 | 29,930.00 | 29,970.00 | 30,000.00 | 29,730.00 | 29,730.00 | 29,570.00 | 29,415.00 | 27,315.00 | |
Commercial — Risk-Based (Fully Insured) | 7,575.00 | 7,655.00 | 7,725.00 | 8,165.00 | 8,440.00 | 8,440.00 | 8,410.00 | 8,845.00 | 8,900.00 | 8,735.00 | 8,545.00 | 8,115.00 | |
Commercial — Fee-Based (Self-Funded / ASO) | 22,180.00 | 22,265.00 | 22,340.00 | 21,485.00 | 21,490.00 | 21,530.00 | 21,590.00 | 20,885.00 | 20,830.00 | 20,835.00 | 20,870.00 | 19,200.00 | |
Community & Senior (Public & Senior) — Total People Served3 | 18,545.00 | 18,605.00 | 18,985.00 | 20,110.00 | 20,195.00 | 20,145.00 | 20,125.00 | 19,615.00 | 19,600.00 | 19,515.00 | 19,765.00 | 19,895.00 | |
Medicare Advantage (Individual & Group MA) | 7,605.00 | 7,565.00 | 7,555.00 | 8,445.00 | 8,435.00 | 8,350.00 | 8,245.00 | 7,845.00 | 7,810.00 | 7,770.00 | 7,760.00 | 7,695.00 | |
Medicaid (Community & State Managed Care) | 6,695.00 | 6,780.00 | 7,160.00 | 7,380.00 | 7,460.00 | 7,490.00 | 7,570.00 | 7,435.00 | 7,450.00 | 7,410.00 | 7,680.00 | 7,845.00 | |
Medicare Supplement (Standardized Medigap) | 4,245.00 | 4,260.00 | 4,270.00 | 4,285.00 | 4,300.00 | 4,305.00 | 4,310.00 | 4,335.00 | 4,340.00 | 4,335.00 | 4,325.00 | 4,355.00 | |
Supplemental — Medicare Part D Stand-Alone Prescription Drug Plans | 2,690.00 | 2,710.00 | 2,740.00 | 2,770.00 | 2,795.00 | 2,800.00 | 2,835.00 | 3,050.00 | 3,055.00 | 3,065.00 | 3,085.00 | 3,315.00 | |
Supplemental — International / South American Medical Benefits | 1,140.00 | 1,145.00 | 1,160.00 | 1,160.00 | 1,160.00 | 1,165.00 | 1,160.00 | 1,330.00 | 1,335.00 | 1,330.00 | 2,295.00 | 5,540.00 | |
Optum Health — Total Consumers Served(M)1 | 92 | 93 | 93 | 92 | 93 | 95 | 95 | 100 | 104 | 104 | 104 | 103 | |
Optum Health — Fully Accountable Value-Based Care Patients(M) | 5 | 4.70 | |||||||||||
Optum Rx — Quarterly Adjusted Scripts Fulfilled(M) | 393 | 387 | 383 | 424 | 414 | 414 | 408 | 422 | 407 | 399 | 395 | 400 | |
Optum Insight — Aggregate Contract Revenue Backlog | 31.10 | 32.10 | 32.10 | 32.90 | 32.80 | 32.80 | 32.60 | 32.80 | 32.10 | ||||
GAAP Remaining Performance Obligations (RPO — Non-Cancelable Long-Term Contracts)($M) | 10,700 | 11,000 | 11,700 | 11,600 | 11,900 | 12,400 | 12,700 | 13,000 | 14,000 | 14,300 | 11,800 | ||
Consolidated Medical Care Ratio (MCR = Medical Costs / Premiums)(%) | 88.4% | 86.7% | 83.9% | 89.1% | 89.9% | 89.4% | 84.8% | 85.5% | 85.2% | 85.1% | 84.3% | ||
Consolidated Operating Cost Ratio (OCR = Operating Costs / Total Revenues)(%) | 12.8% | 12.7% | 13.8% | 12.9% | 13.5% | 12.3% | 12.4% | 13.2% | 13.3% | 14.1% | |||
Return on Shareholders' Equity (ROE — Annualized)(%) | 22.3% | 26.2% | 9.9% | 14.4% | 26.8% | 23.7% | 26.3% | 19.2% | 28.2% | ||||
Debt-to-Total-Capital Ratio(%) | 41.7% | 41.2% | 42.9% | 43.9% | 44.1% | ||||||||
Days Claims Payable (DCP)(days) | 47 | 47 | 49 | 44 | 46 | 45 | 46 | 47 | 47 | 45 | 47 | ||
Days Sales Outstanding (DSO)(days) | 17 | 18 | 22 | 19 | 19 | 20 | 22 | 21 | |||||
Net Favorable (Unfavorable) Medical Reserve Development (Quarterly)($M) | 610 | 860 | 140 | 80 | 70 | ||||||||
Medical Costs Payable — Ending Liability Balance($M) | 39,352 | 38,930 | 39,659 | 39,337 | 40,181 | 38,427 | 37,136 | 34,224 | 33,951 | 32,547 | 34,032 | 32,395 | |
Total Medical Claims Incurred (Rollforward)($M)1 | 75,358 | 73,489 | 82,041 | 79,958 | 78,585 | 73,411 | 67,035 | 65,957 | 65,458 | 65,735 | 62,231 | ||
Medical Claims Incurred — Related to Prior Years (Prior Year Development)($M) | -200 | -1,050 | -110 | 290 | 0 | -320 | -100 | -210 | -80 | -310 | -80 | ||
Total Medical Claims Paid (Cash Outflow)($M)1 | 76,094 | 73,226 | 82,424 | 78,210 | 77,295 | 70,496 | 66,783 | 64,464 | 66,764 | 63,411 | 62,628 | ||
Medical Claims Paid — Related to Prior Years($M) | 3,269 | 29,205 | 837 | 1,455 | 2,329 | 26,669 | 437 | 1,208 | 3,128 | 24,759 | 919 | ||
UnitedHealthcare Segment — Total Revenue($M)4 | 86,330 | 86,017 | 86,265 | 87,113 | 87,070 | 86,103 | 84,617 | 74,132 | 74,853 | 73,866 | 75,357 | ||
UnitedHealthcare Medicare & Retirement Revenue($M) | 42,420 | 42,390 | 42,082 | 43,601 | 43,356 | 42,623 | 41,705 | 34,188 | 34,904 | 34,904 | 35,486 | ||
UnitedHealthcare Community & State (Medicaid) Revenue($M) | 23,702 | 23,635 | 24,065 | 23,776 | 23,839 | 23,711 | 23,064 | 20,150 | 20,195 | 19,725 | 20,500 | ||
UnitedHealthcare Employer & Individual — Total Revenue (Domestic + Global)($M)2 | 20,208 | 19,992 | 20,118 | 19,736 | 19,875 | 19,769 | 19,848 | 19,794 | 19,754 | 19,237 | 19,371 | ||
UnitedHealthcare Employer & Individual — Domestic Revenue($M) | 19,223 | 19,048 | 19,206 | 18,875 | 19,049 | 18,950 | 19,066 | 19,019 | 18,985 | 18,646 | 17,839 | ||
UnitedHealthcare Employer & Individual — Global Revenue($M) | 985 | 944 | 912 | 861 | 826 | 819 | 782 | 775 | 769 | 591 | 1,532 | ||
UnitedHealthcare — Unaffiliated (External Customer) Revenue($M) | 85,367 | 85,761 | 86,502 | 85,530 | 84,089 | 74,046 | 73,338 | 74,822 | |||||
Optum Total (Combined Platform) — Total Revenue($M)6 | 66,883 | 65,663 | 63,749 | 70,333 | 69,177 | 67,225 | 63,885 | 65,101 | |||||
Optum Rx (Pharmacy Care Services) — Total Revenue($M)2 | 39,927 | 38,292 | 35,736 | 41,456 | 39,679 | 38,459 | 35,132 | 35,774 | 34,207 | 32,415 | 30,835 | ||
Optum Rx — Unaffiliated (External Client) Revenue($M) | 15,001 | 14,297 | 14,433 | 14,621 | 13,948 | 13,535 | 12,982 | 12,496 | |||||
Optum Rx — Affiliated (Intersegment to UHC) Revenue($M) | 23,242 | 21,398 | 25,195 | 23,790 | 21,137 | 20,554 | 19,373 | 18,281 | |||||
Optum Health (Care Delivery & Value-Based Care) — Total Revenue($M)2 | 22,910 | 23,472 | 24,109 | 25,543 | 25,422 | 24,725 | 24,837 | 25,660 | 25,917 | 27,050 | 26,731 | ||
Optum Health — Unaffiliated (External Payer & Patient) Revenue($M) | 8,879 | 8,867 | 9,510 | 8,640 | 8,802 | 9,855 | 10,092 | 9,724 | |||||
Optum Health — Affiliated (Intersegment to UHC) Revenue($M) | 14,353 | 14,998 | 15,918 | 15,845 | 15,810 | 15,448 | 16,576 | 16,617 | |||||
Optum Insight (Health Technology, Data & Analytics) — Total Revenue($M)2 | 5,474 | 5,402 | 5,125 | 5,044 | 5,320 | 5,232 | 5,027 | 4,781 | 4,931 | 4,543 | 4,502 | ||
Optum Insight — Unaffiliated (External Health System & Payer) Revenue($M) | 1,562 | 1,665 | 1,584 | 1,717 | 1,703 | 1,741 | 1,446 | 1,743 | |||||
Optum Insight — Affiliated (Intersegment) Revenue($M) | 3,556 | 3,118 | 3,290 | 3,268 | 3,091 | 3,086 | 3,070 | 2,731 | |||||
Optum Total — Unaffiliated (External Customer) Revenue($M) | 25,442 | 24,829 | 25,527 | 24,978 | 24,453 | 25,131 | 24,520 | 23,963 | |||||
Optum Total — Affiliated (Intersegment to UHC) Revenue($M) | 39,648 | 38,293 | 43,086 | 41,712 | 38,927 | 37,958 | 37,890 | 36,613 | |||||
Optum Intra-Platform Eliminations($M) | 1,428 | 1,503 | 1,221 | 1,710 | 1,317 | 1,191 | 1,111 | 1,114 | 1,130 | 1,129 | 1,016 | ||
Corporate Intersegment Eliminations (Optum ↔ UnitedHealthcare)($M) | 40,519 | 39,648 | 38,293 | 44,231 | 43,086 | 41,712 | 38,927 | 38,426 | 37,958 | 37,890 | 36,613 | ||
UnitedHealthcare — Earnings from Operations($M)1 | 2,831 | 3,942 | 5,694 | 1,805 | 2,075 | 5,226 | 2,973 | ||||||
UnitedHealthcare — Operating Margin(%) | 4.6% | 6.6% | 2.1% | 2.4% | 6.2% | 5.6% | 5.4% | 5.8% | |||||
Optum Total — Earnings from Operations($M)4 | 3,732 | 4,049 | 3,296 | 2,510 | 3,075 | 3,893 | 4,800 | ||||||
Optum Rx — Earnings from Operations($M)1 | 1,718 | 1,490 | 1,192 | 1,549 | 1,441 | 1,318 | 1,739 | ||||||
Optum Rx — Operating Margin(%) | 3.9% | 3.3% | 3.9% | 3.7% | 3.8% | 4.5% | 4.3% | 3.7% | |||||
Optum Health — Earnings from Operations($M)1 | 735 | 1,190 | 1,141 | 41 | 429 | 1,411 | 1,791 | ||||||
Optum Health — Operating Margin(%) | 5.1% | 4.7% | 1.0% | 1.7% | 5.7% | 8.3% | 7.1% | 7.1% | |||||
Optum Insight — Earnings from Operations($M)1 | 1,279 | 1,369 | 963 | 920 | 1,205 | 1,164 | 1,270 | ||||||
Optum Insight — Operating Margin(%) | 25.3% | 18.8% | 14.4% | 23.0% | 23.2% | 16.0% | 12.0% | 10.9% | |||||
Optum Total — Operating Margin(%) | 6.2% | 5.2% | 3.6% | 4.6% | 6.1% | 7.0% | 6.2% | 5.8% | |||||
UnitedHealthcare — Segment Capital Expenditures($M) | 207 | 204 | 238 | 193 | 196 | 211 | 187 | 183 | |||||
Optum Total — Segment Capital Expenditures (Property, Equipment & Software)($M)3 | 592 | 559 | 652 | 693 | 702 | 780 | 666 | 560 | |||||
Optum Health — Segment Capital Expenditures($M) | 210 | 184 | 282 | 292 | 264 | 256 | 230 | 238 | |||||
Optum Insight — Segment Capital Expenditures($M) | 291 | 306 | 267 | 303 | 353 | 398 | 344 | 245 | |||||
Optum Rx — Segment Capital Expenditures($M) | 91 | 69 | 103 | 98 | 85 | 126 | 92 | 77 | |||||
UnitedHealthcare — Segment Depreciation & Amortization($M) | 176 | 218 | 221 | 221 | 219 | 217 | 221 | 235 | |||||
Optum Total — Segment Depreciation & Amortization($M)3 | 864 | 811 | 878 | 863 | 842 | 824 | 799 | 762 | |||||
Optum Insight — Segment Depreciation & Amortization($M) | 414 | 392 | 359 | 385 | 376 | 332 | 316 | 310 | |||||
Optum Health — Segment Depreciation & Amortization($M) | 260 | 246 | 309 | 262 | 255 | 283 | 277 | 272 | |||||
Optum Rx — Segment Depreciation & Amortization($M) | 190 | 173 | 210 | 216 | 211 | 209 | 206 | 180 | |||||
Amedisys, Inc. (AMED, CIK 0000896262) — Consolidated Net Service Revenue3 | |||||||||||||
Amedisys (AMED, Acquired Aug 2025) — Home Health Segment Revenue($M)6 | 396 | 379 | 372 | 377 | 364 | ||||||||
Amedisys Home Health — Segment Operating Income($M) | 67.3 | 62.3 | 54.5 | 67.1 | 60.8 | ||||||||
Amedisys Home Health — Total Patient Volume (Admissions + Recertifications)2 | 165,842.00 | 163,946.00 | 157,287.00 | 156,358.00 | 156,176.00 | ||||||||
Amedisys Home Health — Total Admissions | 117,002.00 | 119,596.00 | 109,856.00 | 110,188.00 | 112,215.00 | ||||||||
Amedisys Home Health — Total Recertifications | 48,840.00 | 44,350.00 | 47,431.00 | 46,170.00 | 43,961.00 | ||||||||
Amedisys Home Health — Medicare Completed Episodes | 72,245.00 | 69,871.00 | 71,118.00 | 73,000.00 | 72,998.00 | ||||||||
Amedisys Home Health — Average Medicare Revenue per Completed Episode($) | 3,058 | 3,008 | 3,021 | 3,036 | 2,998 | ||||||||
Amedisys Home Health — Total Patient Visits1 | 1,922,747.00 | 1,822,387.00 | 1,829,075.00 | 1,831,990.00 | 1,792,629.00 | ||||||||
Amedisys Home Health — Average Visits per Completed Episode(×) | 12.00 | 11.70 | 12.00 | 12.20 | 11.90 | ||||||||
Amedisys Home Health — Total Cost per Visit($)2 | 121 | 121 | 122 | 118 | 117 | ||||||||
Amedisys Home Health — Clinician Cost per Visit($) | 108 | 108 | 109 | 106 | 105 | ||||||||
Amedisys Home Health — Care Center & Manager Cost per Visit($) | 12.52 | 13.12 | 12.65 | 11.89 | 11.99 | ||||||||
Amedisys (AMED) — Hospice Segment Revenue($M)6 | 215 | 206 | 208 | 204 | 201 | ||||||||
Amedisys Hospice — Segment Operating Income($M) | 54.4 | 49 | 49.7 | 49.9 | 46.9 | ||||||||
Amedisys Hospice — Total Admissions | 12,172.00 | 13,118.00 | 11,488.00 | 12,124.00 | 12,657.00 | ||||||||
Amedisys Hospice — Average Daily Census (ADC) | 13,132 | 12,759 | 13,004 | 12,968 | 12,767 | ||||||||
Amedisys Hospice — Average Discharge Length of Stay (ALOS)(days) | 93 | 94 | 98 | 90 | 92 | ||||||||
Amedisys Hospice — Revenue per Patient Day($) | 180 | 179 | 174 | 173 | 173 | ||||||||
Amedisys Hospice — Cost per Patient Day($) | 91.36 | 92.78 | 89.92 | 88.65 | 90.64 | ||||||||
Amedisys (AMED) — High Acuity Care (Hospital-at-Home / Contessa) Revenue($M)3 | 10.7 | 9.40 | 7.70 | 9.80 | 6.40 | ||||||||
Amedisys High Acuity Care — Segment Operating Income (Loss)($M) | -3.40 | -3.70 | -6.50 | -2.80 | -6.20 | ||||||||
Amedisys High Acuity Care — Full-Risk Admissions | 225 | 277 | 217 | 157 | 139 | ||||||||
Amedisys High Acuity Care — Limited-Risk Admissions | 848 | 722 | 656 | 675 | 622 | ||||||||
Property, Equipment and Capitalized Software, Net1 | |||||||||||||
PP&E — Less: Accumulated Depreciation and Amortization($M) | 7,546 | 6,971 | 7,039 | ||||||||||
Finite-Lived Intangible Assets, Net1 | |||||||||||||
Intangible Assets — Annual / Quarterly Amortization Expense($M) | 373 | 401 | |||||||||||
Total Operating Lease Liabilities (Current + Noncurrent)($M) | 4,615 | 4,889 | 4,898 | ||||||||||
Elevance Health (ELV) — Total Revenue($M)4 | 51,429 | 50,474 | 50,181 | 49,747 | 50,711 | 49,776 | 48,891 | 45,442 | 45,106 | 43,886 | 42,577 | 42,647 | |
Elevance Health (ELV) — Premiums Earned($M) | 41,704 | 41,279 | 41,024 | 40,690 | 41,791 | 41,271 | 40,887 | 36,245 | 36,809 | 35,416 | 35,696 | 35,138 | |
Elevance Health (ELV) — Medical & Health Care Benefits Expense($M) | 37,779 | 37,024 | 35,615 | 38,065 | 38,140 | 36,706 | 35,312 | 33,500 | 32,949 | 30,572 | 30,546 | 31,334 | |
Elevance Health (ELV) — Operating Income($M) | 1,269 | 1,763 | 2,086 | 309 | 1,295 | 2,425 | 3,170 | 673 | 1,408 | 2,765 | 3,016 | 1,284 | |
Elevance Health (ELV) — Medical Claims & Benefits Payable (Ending Liability)($M) | 18,438 | 18,463 | 18,425 | 17,084 | 17,148 | 17,155 | 16,812 | 15,746 | 15,346 | 15,204 | 16,459 | 16,111 | |
CVS Health (CVS — Aetna / Caremark) — Total Revenue($M)4 | 106,096 | 100,426 | 105,693 | 102,871 | 98,915 | 94,588 | 97,710 | 95,428 | 91,234 | 88,437 | 93,813 | ||
CVS Health (CVS — Aetna / Caremark) — Premiums Earned($M) | 35,117 | 33,791 | 34,017 | 33,719 | 34,195 | 32,820 | 30,913 | 30,925 | 30,667 | 30,391 | 25,075 | ||
CVS Health (CVS — Aetna / Caremark) — Medical & Health Care Benefits Expense($M) | 31,485 | 29,358 | 33,066 | 32,020 | 31,317 | 29,135 | 29,543 | 29,922 | 27,853 | 27,803 | 22,518 | ||
CVS Health (CVS — Aetna / Caremark) — Operating Income($M) | 4,703 | 4,680 | 2,112 | -3,207 | 2,381 | 3,374 | 2,368 | 832 | 3,045 | 2,271 | 3,373 | ||
CVS Health (CVS — Aetna / Caremark) — Medical Claims & Benefits Payable (Ending Liability)($M) | 16,203 | 15,404 | 15,329 | 15,300 | 14,296 | 14,565 | 14,984 | 14,521 | 13,850 | 14,387 | 12,067 | ||
The Cigna Group (CI — Evernorth / Cigna Healthcare) — Total Revenue($M)3 | 71,668 | 68,494 | 72,472 | 69,748 | 67,178 | 65,502 | 65,649 | 63,694 | 60,523 | 57,255 | 51,114 | ||
The Cigna Group (CI — Evernorth / Cigna Healthcare) — Premiums Earned($M) | 9,859 | 9,812 | 9,288 | 9,081 | 9,156 | 12,736 | 11,503 | 11,436 | 11,454 | 11,603 | 11,175 | ||
The Cigna Group (CI — Evernorth / Cigna Healthcare) — Medical & Health Care Benefits Expense($M) | 8,430 | 7,924 | 8,260 | 7,842 | 7,749 | 10,498 | 10,166 | 9,527 | 9,515 | 9,440 | 9,280 | ||
The Cigna Group (CI — Evernorth / Cigna Healthcare) — Operating Income($M) | 2,676 | 2,358 | 2,345 | 2,578 | 2,306 | 1,971 | 2,173 | 2,576 | 2,412 | 2,256 | 2,060 | ||
Humana Inc. (HUM — Medicare Advantage / CenterWell) — Total Revenue($M)4 | 39,648 | 32,515 | 32,649 | 32,388 | 32,112 | 29,213 | 29,397 | 29,540 | 29,611 | 26,462 | |||
Humana Inc. (HUM — Medicare Advantage / CenterWell) — Premiums Earned($M) | 37,709 | 30,884 | 30,711 | 30,716 | 30,514 | 27,750 | 27,951 | 28,142 | 28,261 | 25,128 | |||
Humana Inc. (HUM — Medicare Advantage / CenterWell) — Medical & Health Care Benefits Expense($M) | 33,707 | 28,721 | 27,991 | 27,565 | 26,535 | 25,381 | 25,120 | 25,039 | 25,124 | 22,782 | |||
Humana Inc. (HUM — Medicare Advantage / CenterWell) — Operating Income($M) | 1,754 | -808 | 400 | 1,098 | 2,014 | -543 | 728 | 1,141 | 1,236 | -348 | |||
Humana Inc. (HUM — Medicare Advantage / CenterWell) — Medical Claims & Benefits Payable (Ending Liability)($M) | 12,691 | 9,967 | 10,088 | 11,060 | 11,451 | 10,440 | 11,125 | 11,446 | 11,729 | 10,241 | |||
Centene Corporation (CNC — Medicaid / Marketplace) — Total Revenue($M)3 | 53,579 | 49,944 | 49,725 | 49,690 | 48,742 | 46,620 | 40,805 | 42,023 | 39,836 | 40,407 | 39,460 | ||
Centene Corporation (CNC — Medicaid / Marketplace) — Medical & Health Care Benefits Expense($M) | 39,029 | 38,303 | 41,489 | 40,902 | 38,808 | 36,503 | 31,809 | 32,201 | 30,765 | 30,932 | 30,634 | ||
Centene Corporation (CNC — Medicaid / Marketplace) — Operating Income($M) | 1,198 | 1,861 | -1,745 | -6,954 | -458 | 1,534 | 175 | 665 | 1,229 | 1,106 | -194 | ||
Centene Corporation (CNC — Medicaid / Marketplace) — Medical Claims & Benefits Payable (Ending Liability)($M) | 20,262 | 20,627 | 20,544 | 21,493 | 20,117 | 19,911 | 18,308 | 17,995 | 18,173 | 18,109 | 18,000 | ||
Molina Healthcare (MOH — Medicaid / Medicare) — Total Revenue($M)3 | 11,082 | 10,874 | 10,796 | 11,375 | 11,477 | 11,427 | 11,147 | 10,499 | 10,340 | 9,880 | 9,931 | 9,048 | |
Molina Healthcare (MOH — Medicaid / Medicare) — Premiums Earned($M) | 10,457 | 10,244 | 10,172 | 10,715 | 10,841 | 10,868 | 10,628 | 9,983 | 9,694 | 9,446 | 9,504 | 8,362 | |
Molina Healthcare (MOH — Medicaid / Medicare) — Operating Income($M) | 106 | 145 | 83 | -162 | 137 | 373 | 433 | 380 | 467 | 434 | 426 | 316 | |
Molina Healthcare (MOH — Medicaid / Medicare) — Medical Claims & Benefits Payable (Ending Liability)($M) | 4,988 | 4,841 | 4,941 | 4,887 | 4,844 | 4,885 | 4,804 | 4,640 | 4,732 | 4,577 | 4,571 | 4,204 | |
U.S. Personal Consumption Expenditures: Health Care Services (BEA SAAR) | 3,790.30 | 3,699.90 | 3,667.00 | 3,614.90 | 3,529.80 | 3,464.70 | 3,417.80 | 3,358.20 | 3,288.20 | 3,244.40 | 3,159.40 | ||
Total Consolidated Revenues($M)4 | 112,694 | 112,032 | 111,721 | 113,215 | 113,161 | 111,616 | 109,575 | 100,807 | 100,820 | 98,855 | 99,796 | 94,427 | |
Consolidated Premiums Revenue($M) | 87,078 | 88,979 | |||||||||||
Consolidated Products Revenue (Pharmacy)($M) | 14,293 | 13,296 | |||||||||||
Consolidated Services Revenue($M) | 10,246 | 9,754 | |||||||||||
Consolidated Investment and Other Income($M) | 1,077 | 1,132 | |||||||||||
Consolidated Earnings from Operations (GAAP EBIT)($M)5 | 6,563 | 7,991 | 8,990 | 4,315 | 5,150 | 9,119 | 7,773 | ||||||
Consolidated Operating Margin(%) | 7.1% | 8.0% | 3.8% | 4.6% | 8.3% | 8.6% | 8.0% | 7.9% | |||||
Medical Costs($M) | 76,982 | 79,958 | |||||||||||
Operating Costs (SG&A)($M) | 14,369 | 15,223 | |||||||||||
Cost of Products Sold($M) | 13,707 | 12,566 | |||||||||||
Depreciation and Amortization($M) | 1,073 | 1,099 | |||||||||||
GAAP Net Earnings Attributable to UNH Common Shareholders($M)4 | 4,110 | 2,348 | |||||||||||
Non-GAAP Adjusted Net Earnings Attributable to UNH Shareholders($M) | 4,228 | 2,650 | 3,716 | 6,607 | 5,991 | 6,651 | 6,307 | 6,430 | 24,442 | ||||
Earnings Attributable to Noncontrolling Interests($M) | 190 | 195 | |||||||||||
Earnings Before Income Taxes($M)1 | 5,524 | 3,229 | |||||||||||
Interest Expense($M) | 963 | 1,003 | |||||||||||
Provision for Income Taxes($M) | 1,224 | 686 | |||||||||||
GAAP Diluted Earnings Per Share($)2 | 4.56 | 2.59 | |||||||||||
Non-GAAP Adjusted Diluted EPS($) | 4.69 | 2.92 | 4.08 | 7.20 | 6.81 | 7.15 | 6.80 | 6.91 | 6.16 | ||||
Diluted Weighted-Average Common Shares(M) | 902 | 908 | |||||||||||
Total Consolidated Assets($M)4 | 312,782 | ||||||||||||
Cash and Short-Term Investments($M) | 28,549 | ||||||||||||
Long-Term Investments($M) | 58,064 | ||||||||||||
Accounts Receivable, Net($M) | 20,543 | ||||||||||||
Goodwill($M) | 110,645 | 110,512 | 110,499 | 110,340 | 107,677 | 107,566 | 106,734 | 105,978 | 105,436 | 105,664 | 103,732 | ||
Total Shareholders' Equity($M)3 | 104,129 | ||||||||||||
Short-Term Borrowings & Current Maturities of Long-Term Debt($M) | 5,617 | ||||||||||||
Long-Term Debt, Less Current Maturities($M) | 68,714 | ||||||||||||
Redeemable Noncontrolling Interests($M) | 1,416 | ||||||||||||
Cash Flows from Operating Activities1 | |||||||||||||
Cash Paid for Acquisitions, Net($M) | 98 | 0 | 73 | 3,702 | 32 | 702 | 1,734 | 8,643 | 25 | 3,006 | 1,747 | ||
4 metrics have no data in the last 12 quarters — .
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Fiscal calendar: UnitedHealth Group operates on a calendar fiscal year ending December 31 (Q1 ends Mar 31, Q2 ends Jun 30, Q3 ends Sep 30, Q4 ends Dec 31). Latest reported company period: Q3 2026 (ended September 30, 2026, filed October 13, 2026 on Form 8-K) and Full-Year FY2025 (ended December 31, 2025, filed March 2, 2026 on Form 10-K).
- 2026 Segment Realignment (Optum Financial): Effective January 1, 2026, UnitedHealth Group transferred Optum Financial (including Optum Bank) from Optum Health to Optum Insight. Prior-period segment revenues, operating earnings, and Optum Health consumers served for FY2024 and FY2025 were recast to conform to the 2026 presentation.
- 2022 UHC Sub-Segment Realignment: Effective January 1, 2022, UnitedHealth Group combined UnitedHealthcare Global and UnitedHealthcare Employer & Individual into UnitedHealthcare Employer & Individual (reported with Domestic, Global, and Total sub-lines).
- Subsidiary Standalone Disclosures (Group 4): Integrates standalone SEC filings of Amedisys, Inc. (AMED, CIK 0000896262, acquired by Optum Health on August 14, 2025) and LHC Group, Inc. (LHCG, CIK 0001303313, acquired by Optum Health on February 22, 2023), plus audited UK Companies House Full Accounts for Egton Medical Information Systems Limited (Company No. 02117205, Optum UK / EMIS, acquired October 2023).
- Parent-Company Schedule I Evaluation: Under 17 CFR § 210.5-04, UNH includes Schedule I (Condensed Financial Information of Registrant) in Form 10-K because its insurance and HMO subsidiaries are subject to state statutory capital and dividend restrictions. Because the parent registrant is a pure holding company with $0 direct operating revenue, consolidated − parent subtraction does not isolate an operating unit; instead, Group 5 reports the exact Schedule I parent capital transfer metrics (cash dividends received from subsidiaries, return of capital, capital contributions, and equity in net assets of subsidiaries) alongside Note 10 Statutory Capital Actual vs. Required.
- Bound & approximate figures excluded from numeric cells per Step 4 rules and recorded here: Optum total patients/consumers narrative bound ('over 120 million patients and consumers'), Optum Health value-based care patients at year-end 2023 ('more than 4.1 million'), Optum Rx specialty pharmaceutical spend in FY2025 ('nearly $100 billion'), 2027 Medicare Advantage 4+ Star plan membership ('at least 69% of members in 4+ Star plans'), and full-year 2026 EPS guidance ('at least $19.50 GAAP EPS; at least $20.50 Adjusted EPS').
- Strict Step 4 compliance: Every cell displays a point figure published by UnitedHealth Group, its subsidiaries (Amedisys, LHC Group, EMIS UK), or official industry sources (CMS Medicaid Managed Care Enrollment Reports, BLS/BEA via FRED, SEC XBRL peer filings), plus the two permitted period splits (Q4 = FY − 9M and quarterly cash flow = YTD − prior YTD, marked with formula).
Data updated 2026-10-24.
Every KPI on its own page
Full history, chart, sources and a citation for each metric
1. Quy mô Khách hàng Phục vụ & Khối lượng Vận hành — UnitedHealthcare & Optum (Core Operational KPIs)
- UnitedHealthcare — Total Medical Benefits People Served (Domestic)41 periods
- Optum Health — Total Consumers Served (M)40 periods
- Optum Rx — Quarterly Adjusted Scripts Fulfilled (M)40 periods
- Optum Rx — Annual Adjusted Scripts Fulfilled (M)7 periods
- Optum Rx — Total Pharmaceutical Spending Managed9 periods
- Optum Insight — Aggregate Contract Revenue Backlog37 periods
- GAAP Remaining Performance Obligations (RPO — Non-Cancelable Long-Term Contracts) ($M)15 periods
2. Hiệu suất Bảo hiểm Y tế & Dự phòng Bồi thường — MCR, OCR, DCP, DSO & Actuarial Reserve Rollforward
- Consolidated Medical Care Ratio (MCR = Medical Costs / Premiums) (%)29 periods
- Consolidated Operating Cost Ratio (OCR = Operating Costs / Total Revenues) (%)28 periods
- Return on Shareholders' Equity (ROE — Annualized) (%)26 periods
- Debt-to-Total-Capital Ratio (%)10 periods
- CMS Premium Revenue Share of Consolidated Revenues (%)9 periods
- Days Claims Payable (DCP) (days)29 periods
- Days Sales Outstanding (DSO) (days)11 periods
- Net Favorable (Unfavorable) Medical Reserve Development (Quarterly) ($M)24 periods
- Medical Costs Payable — Ending Liability Balance ($M)47 periods
- Total Medical Claims Incurred (Rollforward) ($M)42 periods
- Total Medical Claims Paid (Cash Outflow) ($M)42 periods
3. Bóc tách Doanh thu, Lợi nhuận, Tài sản & CapEx theo Mảng, Tiểu mảng UHC & Giao dịch Nội bộ (Affiliated vs. Unaffiliated)
- UnitedHealthcare Segment — Total Revenue ($M)26 periods
- Optum Total (Combined Platform) — Total Revenue ($M)8 periods
- Corporate Intersegment Eliminations (Optum ↔ UnitedHealthcare) ($M)26 periods
- UnitedHealthcare — Earnings from Operations ($M)7 periods
- Optum Total — Earnings from Operations ($M)7 periods
- UnitedHealthcare — Segment Total Assets ($M)11 periods
- Optum Total — Segment Total Assets ($M)11 periods
- UnitedHealthcare — Segment Capital Expenditures ($M)11 periods
- Optum Total — Segment Capital Expenditures (Property, Equipment & Software) ($M)11 periods
- UnitedHealthcare — Segment Depreciation & Amortization ($M)11 periods
- Optum Total — Segment Depreciation & Amortization ($M)11 periods
4. Dữ liệu Vận hành Độc lập của Công ty Con — Amedisys (AMED), LHC Group (LHCG) & Optum UK (EMIS)
5. Vốn Pháp định Bảo hiểm, Công ty Mẹ (Schedule I), Danh mục Đầu tư, TSCĐ & Lịch Đáo hạn Nợ / Thuê
- Regulated Insurance & HMO Subsidiaries — Actual Statutory Capital & Surplus ($M)0 periods
- Schedule I Parent (Registrant) — Equity in Net Assets of Subsidiaries ($M)10 periods
- Available-for-Sale (AFS) Debt Securities — Fair Value ($M)0 periods
- Held-to-Maturity (HTM) Debt Securities — Carrying / Amortized Cost ($M)0 periods
- Equity Securities Investments — Carrying Value ($M)0 periods
- Property, Equipment and Capitalized Software, Net ($M)0 periods
- Finite-Lived Intangible Assets, Net ($M)0 periods
- Long-Term Debt Maturities — Thereafter (>5 Years) ($M)0 periods
- Total Operating Lease Liabilities (Current + Noncurrent) ($M)8 periods
6. Dữ liệu Quản lý Ngành — CMS Medicaid Managed Care Enrollment theo Bang & Đối thủ Cạnh tranh (ELV, CVS, CI, HUM, CNC, MOH)
- U.S. Total Medicaid Beneficiaries Enrolled (CMS Official National Total)9 periods
- Elevance Health (ELV) — Total Revenue ($M)43 periods
- CVS Health (CVS — Aetna / Caremark) — Total Revenue ($M)42 periods
- The Cigna Group (CI — Evernorth / Cigna Healthcare) — Total Revenue ($M)38 periods
- Humana Inc. (HUM — Medicare Advantage / CenterWell) — Total Revenue ($M)41 periods
- Centene Corporation (CNC — Medicaid / Marketplace) — Total Revenue ($M)42 periods
- Molina Healthcare (MOH — Medicaid / Medicare) — Total Revenue ($M)43 periods
7. Chỉ số Kinh tế Vĩ mô & Lạm phát Y tế Hàng tháng (BLS PPI / CPI Medical Care, Việc làm Y tế, Doanh số Nhà thuốc & BEA PCE)
- U.S. Personal Consumption Expenditures: Health Care Services (BEA SAAR)42 periods
- BLS PPI — Direct Health & Medical Insurance Carriers (PCU524114524114) (×)129 periods
- BLS PPI — General Medical & Surgical Hospitals (PCU622110622110) (×)129 periods
- BLS PPI — Offices of Physicians (PCU621111621111) (×)129 periods
- BLS CPI-U — Medical Care Total (CPIMEDSL) (×)128 periods
- U.S. Employment — Total Health Care Sector (CES6562000101)129 periods
- U.S. Retail Sales — Pharmacies & Drug Stores (MRTSSM44611USS) ($M)128 periods
- U.S. Retail Sales — Health & Personal Care Stores (RSCCAS) ($M)129 periods
8. Bối cảnh Tài chính Hợp nhất & Non-GAAP (Consolidated Financial Context — DB + Q3 2026 Extension)
- Total Consolidated Revenues ($M)47 periods
- Consolidated Earnings from Operations (GAAP EBIT) ($M)7 periods
- GAAP Net Earnings Attributable to UNH Common Shareholders ($M)2 periods
- GAAP Diluted Earnings Per Share ($)2 periods
- Total Consolidated Assets ($M)1 periods
- Total Shareholders' Equity ($M)1 periods
- Cash Flows from Operating Activities ($M)0 periods